Acondroplasia: una revisión sistemática y comprensiva de la literatura
Ibero Ciencias - Revista Científica y Académica · 19.11.2026 · 5 (4) · 2047-2059
DOI: 10.63371/ic.v5.n4.a1897 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ibero Ciencias - Revista Científica y Académica, online erschienen am 19.11.2026. Verfasst von Camila Alejandra Arguello Layedra und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Achondroplasia, which represents the most common non-lethal skeletal dysplasia worldwide, is an example of how a small genetic alteration can have major effects on human development. This condition, in most cases, is caused by a dominant mutation in the FGFR3 gene, which is responsible for regulating bone development. The present study aims to provide a systematic review that allows achondroplasia to be understood in all its dimensions. It considers not only its genetic and biological bases, but also its main clinical manifestations, associated complications, and the most advanced therapeutic strategies. To guide the search and selection of information, the recommendations of the PRISMA statement were used. Internationally recognized databases, such as PubMed, Scopus, and Web of Science, were consulted, with emphasis on recent studies of high methodological rigor published between 2018 and 2025. After filtering and analyzing the literature, 42 relevant studies were selected for this analysis. The results indicate that, in most cases, achondroplasia is associated with the G380R mutation in the FGFR3 gene, which induces continuous activation of the receptor and, therefore, abnormal cartilage growth. Clinically, patients usually present disproportionate short stature, shortening of the limbs, macrocephaly, and characteristic facial features. In addition, complications such as respiratory problems, neurological disorders, and progressive orthopedic diseases may occur. Regarding treatment, although it has traditionally focused on symptoms, new therapeutic options have recently been proposed. One of the most important is the use of vosoritide, which has been shown to increase growth in children with achondroplasia. In conclusion, achondroplasia is a well-characterized genetic disease that continues to pose significant clinical challenges. Therefore, continued research is a priority in order to help improve the quality of life of people with this condition.
Zitieren
APA
Layedra, C. A. A., Abril, D. P. S., Andrade, L. N. P., Cortés, E. N. P., & Delgado, A. P. T. (2026). Acondroplasia: una revisión sistemática y comprensiva de la literatura. Ibero Ciencias - Revista Científica y Académica, 5(4), 2047-2059. https://doi.org/10.63371/ic.v5.n4.a1897
Vancouver
Layedra CAA, Abril DPS, Andrade LNP, Cortés ENP, Delgado APT. Acondroplasia: una revisión sistemática y comprensiva de la literatura. Ibero Ciencias - Revista Científica y Académica. 2026;5(4):2047-2059. doi:10.63371/ic.v5.n4.a1897
BibTeX
@article{Layedra2026,
author = {Layedra, Camila Alejandra Arguello and Abril, Daniela Paulina Sailema and Andrade, Leslie Nicole Pérez and Cortés, Emily Nicol Paredes and Delgado, Ana Paula Trejos},
title = {Acondroplasia: una revisión sistemática y comprensiva de la literatura},
journal = {Ibero Ciencias - Revista Científica y Académica},
year = {2026},
volume = {5},
number = {4},
pages = {2047--2059},
doi = {10.63371/ic.v5.n4.a1897}
}
EUVIMED